Do indica and sativa labels matter when it comes to cannabis?
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
24 results for “sativa”
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. […]
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
New research suggests certain terpenes may be a viable medication for fibromyalgia and post-surgical pain relief.
CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer.
Researchers found that terpenes found in cannabis were as effective as morphine at reducing chronic neuropathic pain.
Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer a transcendent experience. These […]
Exploring the cutaneous Endocannabinoid System and its potential applications in treating various dermatological conditions.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
In a new extract from the Principles of Cannabinology Handbook, Viola Brugnatelli and Fabio Turco, examine whether cannabis could play a role in tackling the global obesity crisis. Obesity has […]
An expert explains everything you need to know about the entourage effect.
In a landmark new collaboration, the CBD by BRITISH CANNABIS™ range of pharmacy-quality CBD food supplements is set to become available on prescription to pain patients for the first time […]
CBD Calm explores why choosing a product that contains additional terpenes may offer a broad spectrum of potential benefits. CBD Calm specialises in creating pure-strength CBD products that consumers can […]
Cannabis consumers had ‘better outcomes’ and ‘mortality’ than non-users.
Dave Barton, co-founder and creative director at cannabis content agency, thermidor<, explores the challenges brands face in marketing medical cannabis and wonders whether any of them are actually doing it […]
A UK cannabis prescriber shares what he has learned on his journey so far.
Researchers have proposed a safer, more consistent way to produce hexahydrocannabinols (HHCs.
The UK Court of Appeal does not consider hemp flower with a THC content below 0.2% as ‘a narcotic drug’.
A UK cannabis prescriber shares what he has learned on his journey so far.
Hemp Point explores the key differences between RSO and whole-plant CBD .
The ‘legal high’ Hexahydrocannabinol, better known as HHC, is on the rise across Europe. Here’s what you need to know.